HEALTHCARE | Staff Reporter, Taiwan

Digital health partnership tipped to ramp up in Taiwan

Pharma firms will progressively invest in internet and mobile-based technologies.

Digital health partnerships in Taiwan are likely to rise in frequency in the future, as it gradually gains more attention from firms operating at the intersection of technology and medical science, according to a report from Fitch Solutions.

The report explained that digital health will also transform healthcare in Taiwan by delivering a better patient experience whilst lowering costs. The country will also utilise its competitive advantages in IT and medicine to deliver better care and enhance the health of the population.

For instance, MediCloud was launched to allow healthcare providers to query patients’ medical records in the National Health Insurance (NHI) system, whilst the PharmaCloud system provides prescription drug information to physicians and pharmacists.

Data is also becoming more important in the treatment paradigm, with text mining and big data analytics playing a fundamental role in processing data at an aggregate level to understand patterns of usage. This will then help make medicines more effective.

“As such, we believe that pharmaceutical companies will progressively invest in internet and mobile-based technologies in Taiwan,” the report added.

Furthermore, digital health will continue to strengthen healthcare operations in Taiwan. President Tsai Ing-wen pledged to push ahead with the transformation of Taiwan’s healthcare sector in December 2020 as the country strives to sharpen its competitive edge internationally.

One of the objectives is the digital transformation of Taiwan’s healthcare industry, noting that incorporating the Internet of Things, 5G, cloud computing, and other key technologies are pivotal in making Taiwan a hub for digital health.

The other objective is to better control healthcare-related materials with the country working to guarantee enough supply of testing technology, medical equipment, active pharmaceutical ingredients and vaccines to prepare for health crises to come. This will be made through the strategic deployment of available resources and policy incentives.

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.